Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

NCT00271063 is registered in ClinicalTrials.gov with Callisto Pharmaceuticals as lead sponsor.

NCT NCT00271063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00271063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Lead sponsor
Callisto Pharmaceuticals
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2005
Completion date
April 30, 2008
Enrollment
34 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia